Abstract：【Objective】To investigate the expression of matrix metalloproteinase-9 (MMP-9), B-cell lymphoma-2 gene (bcl-2), and heat shock protein 90 alpha (HSP90α) in non-small cell lung cancer (NSCLC) tissues and its clinical significance.【Methods】The pathological tissues of 62 patients with NSCLC were collected and taken as the observation group. There were 30 cases in which the normal lung tissues were adjacent to the cancer tumors with a distance to the tumor of a margin > 3 cm. These 30 cases were determined to be the control group. The expression levels of MMP-9, bcl-2, and HSP90α in pathological tissues and cancer adjacent tissues were determined, and the correlation between the expression of each protein and clinical pathological factors was analyzed.【Results】The expression level of and positive rate of MMP-9 mRNA, bcl-2 mRNA, and HSP90α mRNA in the observation group were all higher than those in the control group (P<0.05). There were significant differences in the positive rates of MMP-9 and HSP90 protein between patients with NSCLC of different TNM stages, with or without lymph node metastasis (P<0.05). There were significant differences in the positive rates of bcl-2 protein between patients with NSCLC with different tissue types (P<0.05). 【Conclusion】The positive rates of MMP-9, bcl-2, and HSP90α in non small cell lung cancer tissues are higher than those in cancer adjacent normal tissues. Expression of MMP-9 and HSP90 is related to TNM stage and lymph node metastasis, and expression of bcl-2 protein is related to NSCLC tissue types.
张智光;任民;胡芸海;马骏;陈志远. NSCLC组织中MMP-9、bcl-2及HSP90α表达及其临床意义[J]. 医学临床研究, 2017, 34(1): 36-38.
ZHANG Zhi-guang, REN Min, HU Yun-hai, et al. Expression of MMP-9, bcl-2, and the HSP90α Protein in Non-Small Cell Lung Cancer Tissues and its Cinical Significance. JOURNAL OF CLINICAL RESEARCH, 2017, 34(1): 36-38.
[1] 周密,倪正义,许俊,等.HSP90和GRP78与非小细胞肺癌完全切除术后吉西他滨化疗预后的相关性研究[J].医学临床研究,2013,30(3):548-551. [2] 李银玲,高辉,王鑫,等.KiSS-1、KiSS-1受体GPR54及基质金属蛋白酶-9与非小细胞肺癌侵袭转移的关系[J].现代肿瘤医学,2011,19(8):1487-1490. [3] 宋仕茂,何晓文.MMP-9及TIMP-1在非小细胞肺癌中的表达及意义[J].现代肿瘤医学,2013,21(9):1978-1981. [4] Young Ho Seo,Ju Hui Jeong.Synthesis of Butein Analogues and their Anti-proliferative Activity Against Gefitinib-resistant Non-small Cell Lung Cancer (NSCLC) through Hsp90 Inhibition[J].Bull Korean Chem Society,2014,35(5):1294-1298. [5] Young Ho Seo.Discovery of Licochalcone A as a Natural Product Inhibitor of Hsp90 and Its Effect on Gefitinib Resistance in Non-Small Cell Lung Cancer (NSCLC)[J].Bull Korean Chem Society,2013,34(6):1917-1920. [6] 蒋朋朋,刘继先,吴昊,等.Bcl-2在非小细胞肺癌组织中的表达及临床意义[J].安徽医科大学学报,2013,48(3):298-301. [7] 李军,王晓敏,宋张骏,等.非小细胞肺癌中Ki-67和BCL-2表达的临床意义及预后价值[J].临床与实验病理学杂志,2012,28(8):921-924. [8] 任德发,胡福荣,邵力伟,等.WWOX、Bcl-2在非小细胞肺癌中的表达及意义[J].武汉大学学报(医学版),2014,35(6):914-916,921.
2017, Vol. 34 
